Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Frank: Studies to Maximize Immunogenicity |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Guinea Pig |
| Stage: | Assays Completed |
| Study Start Date: | 2015-05-14 |
| Study Made Public: | 2015-12-30 |
Title
Guinea pig immunizations comparing JRFL gp140 or BG505 SOSIP trimers +/- incorporation to complement activating beta-glucan particles
Description
CAVD 490 is a preclinical guinea pig study comparing JRFL gp140 or BG505 SOSIP trimers with and without complement activating beta-glucan particles.
Sign in to see full information about this study and to download study data.
Products
Alum B-glucan JRFL gp140 BG505 SOSIP - formaldehyde BG505 SOSIP - glutaraldehydeIntegrated data
NAb
Non-integrated data
No non-integrated data is available for this study.